Ann: New Health Sensor Patent Applications Covering Gaming, Computer Devices, and Other Electronic Hardware, page-206

Thought it was worth reading the original ASX release on the Mobvoi/Cardiex deal back in Sept 2019.
Just wanting to highlight some of the commercial implications Craig highlighted in the release of what now seems to be the imminent launch across multiple Mobvoi devices ( TicWatch Pro Ultra, TicWatch GTH Plus , TicWatch GTH Pro and possibly a mystery device , TicWatch Apollo ).

Commercially it is expected that the partnership would result in a seven-figure royalty for the initial 12 months of sales commencing FY2021 on launch of the first Mobvoi wearable device “powered by ATCOR”. This assumes a single device integration at launch

Magnitude of royalty payments depends on ASP (average selling price) of the wearable device, but expectation is between 3-5% of ASP based on current commercial discussions.

Secondary revenue streams will derive from subscription services that are powered by the ATCOR smart-watch and smart-phone apps. The commercial approach is a freemium model whereby basic versions of both apps with basic smart heart health ecosystem features are easily accessible and free to download. However, a monthly subscription fee will apply on a per-user level to unlock premium features that deliver a richer and more engaging user experience created on the foundation of relevant and actionable insights on the user’s cardiovascular health..

Overall, the combination of royalty fee per unit of sales and recurring subscription fee creates a sustainable and scalable razor-razor blade model that leverages our core technology and enables collection of user physiological data. The key is producing a creatively engaging user experience for atar get audience with very short attention span and converting each new user into a “stubbornly” sticky customer. All of the above add up to a significant and material financial and strategic opportunity for the Cardiex Group.

Finally, it’s worth repeating the significance of this transaction for us as a company and for our shareholders. We now have a future revenue generating partnership and are part of the Google network via the largest platform for Google’s Wear OS platform in the biggest market in the world. The JDA and partnership is a testament to the value of our technology as a unique and market differentiating platform for powering next generation consumer health technologies.”